Rescue of human cytomegalovirus strain AD169 tropism for both leukocytes and human endothelial cells

References

1. Bolovan-Fritts C. A., Wiedeman J. A. 2001; Human cytomegalovirus strain Toledo lacks a virus-encoded tropism factor required for infection of aortic endothelial cells. J Infect Dis 184:1252–1261
   [Google Scholar]
2. Bolovan-Fritts C. A., Wiedeman J. A. 2002; Mapping the viral genes determinants of endothelial cell tropism in human cytomegalovirus. J Clin Virol 25:S97–109
   [Google Scholar]
3. Cha T.-H., Tom E., Kemble G. W., Duke G. M., Mocarski E. S., Spaete R. S. 1996; Human cytomegalovirus clinical isolates carry at least 19 genes not found in laboratory strains. J Virol 70:78–83
   [Google Scholar]
4. Dargan D. J., Jamieson F. E., Maclean J., Dolan A., Addison C., McGeoch D. J. 1997; The published DNA sequence of human cytomegalovirus strain AD169 lack 929 base pairs affecting genes UL42 and UL43. J Virol 71:9833–9836
   [Google Scholar]
5. Fish K. N., Soderberg-Naucler C., Mills L. K., Stenglein S., Nelson J. A. 1998; Human cytomegalovirus persistently infects aortic endothelial cells. J Virol 72:5661–5668
   [Google Scholar]
6. Gerna G., Revello M. G., Percivalle E., Zavattoni M., Parea M., Battaglia M. 1990; Quantification of human cytomegalovirus viremia by using monoclonal antibodies to different viral proteins. J Clin Microbiol 28:2681–2688
   [Google Scholar]
7. Gerna G., Revello M. G., Percivalle E., Morini F. 1992; Comparison of different immunostaining techniques and monoclonal antibodies to the lower matrix phosphoprotein (pp65) for optimal quantitation of human cytomegalovirus antigenemia. J Clin Microbiol 30:1232–1237
   [Google Scholar]
8. Gerna G., Percivalle E., Torsellini M., Revello M. G. 1998a; Standardization of the human cytomegalovirus antigenemia assay by means of in vitro-generated pp65-positive peripheral blood polymorphonuclear leukocytes. J Clin Microbiol 36:3585–3589
   [Google Scholar]
9. Gerna G., Zavattoni M., Baldanti F., Sarasini A., Chezzi L., Grossi P., Revello M. G. 1998b; Human cytomegalovirus (HCMV) leukoDNAemia correlates more closely with clinical symptoms than antigenemia and viremia in heart and heart-lung transplant recipients with primary HCMV infection. Transplantation 65:1378–1385
   [Google Scholar]
10. Gerna G., Percivalle E., Baldanti F., Sozzani S., Lanzarini P., Genini E., Lilleri D., Revello M. G. 2000; Human cytomegalovirus replicates abortively in polymorphonuclear leukocytes after transfer from infected endothelial cells via transient microfusion events. J Virol 74:5629–5638
    [Google Scholar]
11. Gerna G., Percivalle E., Baldanti F., Revello M. G. 2002a; Lack of transmission to polymorphonuclear leukocytes and human umbilical vein endothelial cells as a marker of attenuation of human cytomegalovirus. J Med Virol 66:335–339
    [Google Scholar]
12. Gerna G., Percivalle E., Sarasini A., Baldanti F., Revello M. G. 2002b; The attenuated Towne strain of human cytomegalovirus may revert to both endothelial cell tropism and leuko- (neutrophil- and monocyte-) tropism in vitro . J Gen Virol 83:1993–2000
    [Google Scholar]
13. Gerna G., Percivalle E., Sarasini A., Revello M. G. 2002c; Human cytomegalovirus and human umbilical vein endothelial cells: restriction of primary isolation to blood samples and susceptibilities of clinical isolates from other sources to adaptation. J Clin Microbiol 40:233–238
    [Google Scholar]
14. Kahl M., Siegel-Axel D., Stenglein S., Jahn G., Sinzger C. 2000; Efficient lytic infection of human arterial endothelial cells by human cytomegalovirus strains. J Virol 74:7628–7635
    [Google Scholar]
15. MacCormac L. P., Grundy J. E. 1999; Two clinical isolates and the Toledo strain of cytomegalovirus contain endothelial cell tropic variants that are not present in the AD169, Towne or Davis strains. J Med Virol 57:298–307
    [Google Scholar]
16. Mocarski E. S., Prichard M. N., Tan C. S., Brown J. M. 1997; Reassessing the organization of the UL42–UL43 region of the human cytomegalovirus strain AD169 genome. Virology 239:169–175
    [Google Scholar]
17. Penfold M. E. T., Dairaghi D. J., Duke G. M., Saederup N., Mocarski E. S., Kemble G. W., Schall T. 1999; Cytomegalovirus encodes a potent chemokine. Proc Natl Acad Sci U S A 96:9839–9844
    [Google Scholar]
18. Plotkin S. A., Furukawa T., Zygraich N., Huygelen C. 1975; Candidate cytomegalovirus strain for human vaccination. Infect Immun 12:521–527
    [Google Scholar]
19. Revello M. G., Percivalle E., Arbustini E., Pardi R., Sozzani S., Gerna G. 1998; In vitro generation of human cytomegalovirus pp65 antigenemia, viremia, and leukoDNAemia. J Clin Invest 101:2686–2692
    [Google Scholar]
20. Revello M. G., Baldanti F., Percivalle E., Sarasini A., De-Giuli L., Genini E., Lilleri D., Labò N., Gerna G. 2001; In vitro selection of human cytomegalovirus variants unable to transfer virus and virus products from infected cells to polymorphonuclear leukocytes and to grow in endothelial cells. J Gen Virol 82:1429–1438
    [Google Scholar]
21. Rowe W. P., Hartley J. W., Waterman S., Turner H. C., Hubner R. J. 1956; Cytopathogenic agent resembling human salivary gland virus recovered from tissue cultures of human adenoids. Proc Soc Exp Biol Med 92:418–422
    [Google Scholar]
22. Sinzger C., Kahl M., Laib K., Klingel K., Rieger P., Plachter B., Jahn G. 2000; Tropism of human cytomegalovirus for endothelial cells is determined by a post-entry step dependent on efficient translocation to the nucleus. J Gen Virol 81:3021–3035
    [Google Scholar]
23. Slobbe van Drunen M. E., Hendrickx A. T., Vossen R. C., Speel E. J., Van Dam Mieras M. C., Bruggeman C. A. 1998; Nuclear import as a barrier to infection of human umbilical vein endothelial cells by human cytomegalovirus strain AD169. Virus Res 56:149–156
    [Google Scholar]
24. Weller T. H., Macaulay J. C., Craig J. M., Wirth P. 1957; Isolation of intranuclear inclusion producing agents from infants with illnesses resembling cytomegalic inclusion disease. Proc Soc Exp Biol Med 94:4–12
    [Google Scholar]